Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Biotech/Pharma - IPO
Bay Area's Intersect ENT Secures $55 Million After Hitting The Low End Of Its IPO Range 7/24/2014 11:07:52 AM
Massachusett's Ocular Therapeutix, Inc. (OCUL) Goes IPO At $13 A Share 7/25/2014 6:54:38 AM
SoCal's Atara Biotherapeutics IPO Delayed By New Test Results 7/24/2014 7:55:23 AM
Seattle Biotech Immune Design Corporation (IMDZ) Prices IPO At $12 Per Share, The Low End Of The Range 7/24/2014 9:06:27 AM
San Diego Biotech Pfenex Inc. (PFNX) Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation 7/24/2014 8:06:21 AM
Cancer Biotech Loxo Oncology Sets Terms For $57 Million IPO 7/22/2014 7:21:13 AM
Avalanche Biotechnologies Boosts IPO As 2 More Biotechs Go Public This Week 7/22/2014 6:41:08 AM
Catalent Pharma Solutions Sees IPO Of 42.5 Million Shares Priced Between $19-$22/Share 7/21/2014 6:09:57 AM
Auris Medical AG Commences Proposed Initial Public Offering Of Common Shares 7/21/2014 7:36:05 AM
Seres Health Makes Push For First Drug, And IPO, Of Microbiome Era 7/17/2014 7:19:54 AM
Cambridge's SAGE Therapeutics Ups Proposed IPO Deal Size 7/17/2014 8:46:21 AM
Rare Disease Biotech Bio Blast Pharma Sets Terms For $40 Million IPO 7/16/2014 6:48:38 AM
Menlo Park's Intersect ENT Latest Health/Bio IPO To Lower Target 7/15/2014 7:17:24 AM
Genocea Biosciences Elects Not To Pursue Public Offering 7/16/2014 10:40:34 AM
Absorbable Drugs Biotech Innocoll, Inc. Sets Terms For $75 Million IPO 7/16/2014 6:17:34 AM
1234567
//-->